Guangdong treasure temple medical group was established in May 1999, the registered capital of 50 million yuan. Is in the proprietary Chinese medicines, chemical raw materials and preparations, bio-pharmaceutical preparations and other fields set R & D, design, manufacture, sale, logistics, promotion as one of the major pharmaceutical companies. The company has been in "creating value for customers, creating the future for employees, creating benefits for shareholders, creating prosperity for the community," committed to the development of new drugs, the company has a number of exclusive new drug varieties and a number of 20 patents for inventions. Group companies have passed the United States EQA international quality certification, drug quality management practices GSP certification, pharmaceutical production and management practices GMP certification. Baoruitan Group owns a number of subsidiaries under its command, large-scale production base and 20,000 square meters in line with the GSP standard warehouse, the product involves a number of subjects, the sales network throughout the country, the company is in full swing IPO listing process.
Guangdong treasure temple medical group has been adhering to the "quality first, the credibility of the first, the customer first, comprehensive services," business philosophy, operating its subsidiaries: Guangxi Bao Ruitan Pharmaceutical Co., Ltd., Guangxi Wanshan Hong Pharmaceutical Co., Ltd. Guangxi Ming Pharmaceutical Co., Ltd., Guangdong Bao Rui Tan Pharmaceutical Group Co., Ltd. One pharmaceutical company workshop in line with national GMP standards, with Chinese medicine extraction, tablets, capsules, granules, syrups, tinctures, oral liquid, lotion, powder, raw material agent, and other production lines. At present, the group company plans to build "Bao Rui Tan (BRT)" brand as a healthy express image to enter the national OTC market and e-commerce network market opened B2C new platform to promote greater development of Corndil medicine.
In today's economic globalization, China's pharmaceutical industry has been pushed into an important stage of global development. In face of the new opportunities and new challenges of international industrial transfer, domestic medical reform and industry consolidation, Baoruitan is entering a new era of rapid development . Based on the present and future prospects, Baoruitan will continue to uphold its entrepreneurial spirit of "integrity, pragmatism and efficient innovation" and integrate the superior resources of all parties so as to provide safe, efficient, green and environment-friendly medicines to human beings. "One Stop, Healthy Express - BRT Poetan" will be the unifying slogan of the company's brand and will be directed at consumers with the image of "efficient, fast, green and healthy".
